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Abstract
It has long been established that the sheep Prnp genotype influences the susceptibility to scrapie, and some
studies suggest that it can also determine several aspects of the disease phenotype. Other studies, however,
indicate that the source of infection may also play a role in such phenotype. To address this question an
experiment was set up in which either of two different natural scrapie sources, AAS from AA136 Suffolk and VVC
from VV136 Cheviot sheep, were inoculated into AA136, VA136 and VV136 sheep recipients (n= 52). The
immunohistochemical (IHC) profile of disease-associated PrP (PrPd) accumulation in the brain of recipient sheep was
highly consistent upon codon 136 homologous and semi-homologous transmission, but could be either similar to
or different from those of the inoculum donors. In contrast, the IHC profiles were highly variable upon
heterologous transmission (VVC to AA136 and AAS to VV136). Furthermore, sheep of the same Prnp genotype could
exhibit different survival times and PrPd profiles depending on the source of infection, and a correlation was
observed between IHC and Western blot profiles. It was found that additional polymorphisms at codons 112 or 141
of AA136 recipients resulted in a delayed appearance of clinical disease or even in protection from infection. The
results of this study strongly suggest that the scrapie phenotype in sheep results from a complex interaction
between source, donor and recipient factors, and that the Prnp genotype of the recipient sheep does not explain
the variability observed upon codon 136 heterologous transmissions, arguing for other genetic factors to be
involved.
Introduction
Classical scrapie is a transmissible spongiform encephal-
opathy (TSE) that occurs as a natural infectious and
contagious disease of sheep and goats. It can also be
transmitted experimentally by a variety of routes, not
only to its natural host species but also to other mam-
mals, notably laboratory rodents. The aetiological agent
of scrapie is thought by many to be a prion, which is
defined as an abnormal and infectious isoform of a cellu-
lar prion protein, PrPc [1], encoded by the host Prnp
gene [2]. The abnormal isoforms accumulate during in-
fection and may be defined operationally as protease-
resistant PrP (PrPres) when detected by methods that use
enzyme digestion, or disease-associated PrP (PrPd) when
detected by methods such as immunohistochemistry
(IHC).
It has long been established that susceptibility of sheep
to scrapie is modulated by polymorphisms of the Prnp
gene. While several polymorphisms may influence sus-
ceptibility, those at codons 136 and 171 -which in the
wild-type allele encode alanine (A) and glutamine (Q),
respectively- are understood to be particularly influen-
tial. Thus, sheep encoding valine (V) at codon 136
(VV136QQ171 and VA136QQ171) show enhanced suscepti-
bility compared to AA136QQ171 animals, while those en-
coding arginine (R) at codon 171 (AA136RR171 and
AA136RQ171) show increased resistance [3-6]. “In vitro”
assays have led some researchers to postulate that such
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relative susceptibility or resistance may result from the
efficiency by which different polymorphic variants of
PrPc can convert to PrPres [7].
Several studies on natural scrapie indicate that the
sheep Prnp genotype, in particular at the two above
mentioned codons, can influence not just the suscepti-
bility to infection but also different aspects of the disease
phenotype. These include survival times [8], clinical
signs [9,10], vacuolar lesion profiles [11] and IHC pat-
terns of PrPd accumulation in the brain [12]. Other stud-
ies dealing with both natural and experimental sheep
scrapie and with experimental bovine spongiform en-
cephalopathy (BSE) in sheep have indicated that the
TSE source, isolate, agent or strain may also play a
role in the pathological [13] and IHC [14-19] pheno-
types of the disease. Similarly, studies of transmission
of TSE isolates to mice have shown that the murine
disease phenotype (incubation period and vacuolar
lesion profile) depends on an interaction between the
TSE agent and host genetic factors [20,21]. Also, spor-
adic Creutzfeldt-Jakob disease of man shows different
phenotypes that correlate with polymorphisms at
codon 129 but, as is also found in sheep [16], two or
more disease phenotypes can be recognised for a sin-
gle PRNP genotype [22,23].
The experiment reported here aimed to determine the
extent to and conditions in which the susceptibility to
scrapie and the disease phenotype in sheep was influ-
enced solely by Prnp genetic factors of the recipients or
also by donor-related factors.
Material and methods
Experimental design
Two different inocula were used to challenge a total of
65 sheep of two breeds and four different Prnp geno-
types by two routes (Table 1). One inoculum (AAS) was
prepared from the brains of 10 Suffolk sheep born in
2000 in a closed flock naturally affected by scrapie, the
clinical, pathological and epidemiological aspects of
which have been reported previously [14,16,24,25]. All
those 10 sheep were Prnp AA136QQ171 genotype and
developed clinical scrapie around two years after birth
(Figure 1A). The other inoculum (VVC) was prepared
from the brains of six clinically affected Cheviot sheep
born in 1998–1999 in another closed flock; the clinical,
pathological and epidemiological aspects of scrapie in
this flock have also been reported previously [26-28]. All
those six sheep were Prnp VV136QQ171 genotype and
developed clinical scrapie also at around two years after
birth (Figure 1b). All donor and recipient sheep were
homozygous for arginine (R) at codon 154.
Table 1 provides details of the inoculations with the
two inocula in the different recipients by either the oral
or subcutaneous route (5 g or 0.5 g tissue equivalent, re-
spectively). The inoculations were carried out between
September and November 2002, when the recipient
sheep were 5–6 months old; these sheep were sourced
from a New Zealand-derived, scrapie-free flock (ARSU,
AHVLA, Addlestone, UK). In summary, the following
inoculations were done: i) “Homologous transmissions”:
VVC to three VV136QQ171 (VV) recipients and AAS to
13 AA136QQ171 (AA) recipients; ii) “Heterologous trans-
missions”: VVC to 13 AA recipients and to 10
AA136RQ171 (RQ) recipients, and AAS to 10 VV recipi-
ents; iii) “Semi-homologous transmissions”: VVC to
three VA136QQ171 (VA) recipients, and AAS to 10 VA
recipients and to 3 RQ recipients. A further 4 sheep
(two AA Suffolk and two VV Cheviot) were kept as
non-inoculated, environmental controls. In total, there
were 17 sheep groups (15 inoculated –see Table 1- and
two environmental controls) that were housed in as
many different pens. Of the 65 inoculated sheep, 43 were
castrated males and 22 were non-mated females.
It should be noted that, at the start of the experiment,
the influence of polymorphisms at codons other than
136, 154 and 171 on the susceptibility to and pathogen-
esis of sheep scrapie was unknown; therefore, amino
acids were determined only at those codons. In 2010,
the full open reading frame of Prnp was determined
retrospectively for most donor and recipient sheep in
the experiment (see below).
Monitoring of clinical disease and post-mortems
Monitoring for clinical signs of scrapie was carried out
daily by a protocol described in detail in Additional file
1 (Table S1.1). Sheep reaching a defined clinical end
point and those culled for welfare reasons were eutha-
nised by barbiturate overdose and necropsies performed.
The latter, as well as sheep that died from intercurrent
disease, were included in the estimations of attack rates,
but excluded from all other analyses performed. Sheep
that did not develop clinical disease by the end of the
experiment were culled at 2400–2500 days post-
inoculation (dpi). All 65 sheep in the experiment and
Table 1 Experimental design
Recipient AAS inoculum VVC inoculum
codon 136 po sc po sc Total
Suffolk AA* 3sh 5 ht 5ht 13
Suffolk AA 3hm 5 ht 5ht 13
Cheviot AA 5 hm 5 hm 3 ht 13
Cheviot VA 5 sh 5 sh 3 sh 13
Cheviot VV 5 ht 5 ht 3 hm 13
Total 21 15 19 10 65
po, “per os” (oral route); sc, subcutaneous route. *codon 171 genotype of
those recipients was RQ; all others were QQ. With regard to Prnp codon 136,
transmissions are: hm, homologous; sh, semi-homologous; ht, heterologous.
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the environmental controls were subjected to the same
necropsy protocol and range of laboratory examinations.
Tissue sampling and immunohistochemistry (IHC)
At post-mortem, samples of the central nervous system
(CNS) were collected, including the whole brain and
three levels of the spinal cord. The brain was halved and
one hemi-brain was frozen at −80°C for biochemical
studies and the other fixed in formaldehyde for IHC
examinations. Following fixation, 7 different brain areas
(frontal cerebral cortex, corpus striatum/basal ganglia,
thalamus/hypothalamus, midbrain, cerebellar cortex/
peduncles, rostral medulla oblongata, and medulla at the
obex) and 3 levels of the spinal cord (3rd cervical, 10th
thoracic and 3rd lumbar) were processed for IHC exam-
ination of PrPd with the rat monoclonal antibody R145,
which binds to amino acid sequence RESQA (222–226)
of ovine PrP (AHVLA, Addlestone, UK), by methods
previously described [14,15].
PrPd scoring in CNS samples, of both inocula donors
and recipient sheep, was carried out using the PrPd pro-
filing method previously described [14,15]. Briefly, the
method involved the scoring from 0 to 3 of five different
patterns of PrPd accumulation: i) intraneuronal, ii) intra-
glial (intramicroglial and intrastrocytic types combined),
iii) extracellular glia-associated (subpial, subependymal,
perivascular, stellate and perivacuolar types combined), iv)
grey matter neuropil-associated (diffuse particulate,
coalescing, perineuronal and linear types combined), and
v) other types (ependymal, vascular plaque and non-
vascular plaque types combined) at the 7 brain areas and
3 spinal cord levels mentioned above.
Western blotting (WB)
Samples of caudal medulla from all 65 recipient sheep
were examined for the detection of PrPres by WB with
P4 and SAF84 monoclonal antibodies (R-biopharm,
Darmstadt, Germany), which bind to amino acid
sequences 93–99 and 160–170 of ovine PrP, respectively.
These samples were analysed once and each gel included
the same positive and negative controls to ensure
consistency of results between different gels.
Samples were treated as described previously [29],
with some minor refinements. Briefly, samples were
homogenised at 20% (w/v) in lysis buffer and frozen at
−20°C overnight. Lysates were then diluted to 10% in
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Figure 1 Diagramatic representation of the global outcome of the experiment (excluding ARQ/ARR recipients and environmental
controls). A: transmissions with AAS inoculum. B: transmissions with VVC inoculum. Survival times in days (dpi) of AAS and VVC inoculum donors
(red and blue squares, respectively), and of ARQ/ARQ (AA, red if Suffolk, orange if Cheviot), VRQ/ARQ (VA, pink, all Cheviot) and VRQ/VRQ (VV,
blue, all Cheviot) recipients, challenged by the oral (triangles) or subcutaneous (circles) route. In white, PrPd-positive sheep dying from
intercurrent conditions or culled for welfare reasons (all of them Cheviot in the case of AAS inoculum and Suffolk in the case of VVC inoculum).
Black circle and triangles, four sheep (two Cheviot and two Suffolk) culled at the end of the experiment which resulted completely negative for
PrPd and PrPres by IHC and WB, respectively. Dotted lines split sheep with additional polymorphisms at codons either 112 (MT, Suffolk) or 141 (LF,
Cheviot) from MMLL sheep (with no additional polymorphisms). Numbers next to each symbol correspond to sheep identification numbers in
Additional file 2.
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lysis buffer and then digested with 50 μg/mL proteinase K
solution for 1 h, at 37°C in agitation. Digestion was termi-
nated by adding 1 mM Pefabloc SC (Roche Diagnostics,
Burgess Hill, West Sussex, UK). Samples were then centri-
fuged at 20 000× g for 1 h at 4°C, the supernatants dis-
carded and the pellets resuspended in 45 μL 2×Sample
Buffer (Invitrogen, Paisley, UK) containing 5 μL of
10× sample reducing agent (Invitrogen, Paisley, UK). Sam-
ples were heated at 100°C for 5 min and once cooled pulsed
for 5 s at 5000 rpm. SDS-PAGE was carried out on 10 μL
of sample on 4-12% Bis-Tris NuPAGE gels (Invitrogen,
Paisley, UK) at 200 V for 40 min. Proteins were electro-
transferred onto Hybond P PVDF membrane (GE Health-
care, Chalfont St Giles, Buckinghamshire, UK) at 30 V for
1 h. Non-specific antigen binding on the membrane was
blocked by soaking in 2% non-fat milk/TBS with 0.1%
Tween20 (Sigma Chemical Company, Poole, Dorset, UK)
and the membranes were probed with either P4 or SAF 84
antibodies. Signal detection and analysis were performed as
previously reported [29].
Prnp genotyping
At the start of the experiment, amino acids at codons 136,
154 and 171 of the ovine PrP were determined by sequen-
cing with an ABI Prism 377 DNA sequencer according to
the manufacturer’s instructions (PE Applied Biosystems;
Warrington, UK). In 2010, and in order to ascertain the ex-
istence of polymorphisms at other codons, blood or brain
tissue samples from 52 recipient sheep (all except the 13
RQ), the 10 donors of the AAS inoculum and the 4 envir-
onmental controls were taken for PCR amplification and
sequencing of the whole open reading frame of the Prnp
gene on an 3130 Genetic Analyzer with the BigDyeW ter-
minator v3.1 cycle sequencing kit as per the manufacturer’s
protocol (PE Applied Biosystems).
Statistical analyses
Differences between transmission groups (defined as the
combination of inoculum source and Prnp genotype of re-
cipient) in terms of survival times were analysed by non-
parametric unpaired t tests (Mann–Whitney; InstatW
GraphPad Softaware, San Diego, USA). The same analyses
were used to determine differences in WB features (mo-
lecular weights of the unglycosylated band and glycopro-
files) between sheep with different PrPd profiles determined
by IHC examinations. Differences in attack rates and fre-
quency of presentation of different clinical signs between
transmission groups were analysed by Fisher’s exact test
(InstatW GraphPad Softaware).
Results
Attack rates, survival times and clinical signs
None of the 13 RQ sheep, either dosed with AAS or VVC
inocula, developed any clinical signs suggestive of scrapie
on routine examinations and were consistently negative in
three serial rectal biopsy examinations performed over a
period of 18 months (results not shown). Two of them died
from intercurrent conditions at 1200 and 1500 dpi and the
remaining 11 were culled at 2200 dpi. None of them
showed any evidence of PrPd or PrPres accumulation in any
of the tissues examined by IHC and WB, respectively. Simi-
larly, the 4 environmental controls were fully negative when
culled at the end of the experiment. None of those 17 sheep
showed any additional polymorphism at any Prnp codon,
and neither did any of the sheep providing the AAS and
VVC inocula.
Of the remaining 52 recipients (Figure 1), none of the 13
VV Cheviot recipients showed additional polymorphisms.
In contrast, 8 of the 13 VA and 11 of 13 AA Cheviot sheep
recipients were LF141 (L, leucine, F, phenylalanine), and 4 of
the 13 AA Suffolk sheep were MT112 (M, methionine, T,
threonine).
A total of 48 of those 52 recipients were diagnosed as
scrapie-infected at post-mortem. Attack rates reached 100%
in all donor/recipient combinations, regardless of the route
of infection, with only one exception: the heterologous
VVC to AA transmissions, for which the attack rate was
69.2% (9/13). The four PrPd and PrPres negative sheep (one
inoculated sc) were long-term survivors culled at the end of
the experiment, more than 2400 dpi. This transmission
group could be split into two: seven recipients with no add-
itional polymorphisms, all of which were scrapie positive at
post-mortem (100% attack rate), and six animals with add-
itional polymorphisms (three MT112 and three LF141); of
these, two each were negative and one each positive (33%
attack rate). The two attack rate figures of non-
polymorphic and polymorphic recipients were significantly
different in the Fisher’s exact test (P=0.02).
Of the 48 scrapie positive sheep, 10 died from intercur-
rent conditions, either after having shown early clinical
signs of scrapie, or in their complete absence; these sheep
did not belong to any particular transmission group (Fig-
ure 1). Amongst the remaining 38 sheep, all of which
reached clinical end point, survival times were shortest in
VVC homologous and semi-homologous transmissions fol-
lowed by AAS homologous transmission to AA sheep with-
out additional polymorphisms. The longest survival times
were observed in semi-homologous AAS to VA transmis-
sions and in the two polymorphic AA recipients challenged
with VVC inoculum. Table 2 provides details of survival
times and of the statistical differences between transmission
groups (individual details can be found in Additional file 2).
A number of non-ideal assumptions were made to obtain
groups large enough to allow statistical analysis; in our
opinion such compromises are justified in view of the ac-
tual data, as follows:
- The two non-polymorphic AA Cheviot sheep inocu-
lated with AAS were grouped together with the two
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non-polymorphic AA Suffolk sheep, as their survival
times were very similar (Figure 1). For the same reason
the only polymorphic AA Suffolk recipient was consid-
ered together with the five polymorphic Cheviot sheep,
all challenged with AAS. Similarly, the only clinically
affected, polymorphic AA Cheviot and AA Suffolk sheep
inoculated with VVC were grouped together in view of
their protracted incubation periods; this arrangement
had no effect on the statistical analyses, as the group
was still too small (Table 2).
- VA recipients of each of the two semi-homologous
transmission groups were considered as a single group
regardless of the presence or absence of additional poly-
morphisms, since these polymorphisms appeared not to
have any effect on survival times in any of the two trans-
mission groups (Figure 1). In fact, the only polymorphic
VA sheep receiving VVC inoculum had the shortest,
though similar, survival time of this group.
- AA recipients either with MT or LF polymorphisms
were considered together as AA sheep with additional
polymorphisms (AA+ in Table 2). Both polymorphisms
had the same effect on the attack rate after VVC chal-
lenge (33%), and the survival time of the MT Suffolk
sheep in the homologous transmission group was prac-
tically the same as that of four of the five LF Cheviot
sheep (Figure 1).
- In some transmission groups, sheep inoculated sub-
cutaneously appeared to have slightly shorter survival
times than those dosed orally (eg. AAS to VA or VVC to
non-polymorphic AA, the survival times of which were
very long and spread regardless of route of challenge),
while in other groups the opposite effect (AAS to VV)
or no effect (AAS to AA) was found (Figure 1). In view
of this the two routes were grouped together.
- Males and females showed no differences in attack
rates or survival times (data not shown).
With these assumptions in mind, the two key findings
of the analysis of survival times were (Table 2):
- The influence of the source of inoculum for each of
the different recipient genotypes. Thus, AA recipients
without additional polymorphisms showed significantly
shorter survival times when challenged with AAS
(679 ± 54 [meandays ± SD]) than in transmissions with
VVC inoculum (1544 ± 294; P< 0.01), while VV and VA
sheep challenged with VVC had significantly shorter sur-
vival times (245 ± 33 and 399 ± 28, respectively) than in
transmissions with AAS inoculum (1400± 200 and
1934± 275, respectively; P< 0.05 in both cases).
- For AA recipients challenged with homologous AAS
inoculum, additional polymorphisms, which resulted in
significantly longer survival times (1195+/-90) compared
to non-polymorphic sheep (679+/-54; P<0.01). The in-
fluence of such polymorphisms could not be tested in
VVC to AA transmissions, as only two of these recipi-
ents were polymorphic; their survival times were how-
ever very protracted (1809 and 2237 days).
Details of the frequency and severity of the different
types of scrapie-associated clinical signs are given in Add-
itional file 1 (Table S1.2). Ataxia was the predominant
clinical sign in all transmission groups, as it was shown by
89% of the affected sheep, while weight loss was the least
common of the clinical signs (24% of cases). Signs of prur-
itus were recorded in 67% of cases in which the VV geno-
type was present, either as inoculum or as recipient,
which was in contrast with 24% of cases in which those
signs were observed in the absence of the VV genotype.
Conversely, dysphagia correlated negatively with the VV
genotype (see details in Additional file 1, Table S1.2).
Table 2 Statistical analysis of differences in survival times
Survival Times AAS to VVC to
AA(4) AA+(6) VA(7) VV(7) VV(3) VA(3) AA(6) AA+(2)
679 ±54 1195±90 1934±275 1400±200 245±33 399±28 1544±294 2023±303
AAS to
AA(4) 679±54
AA+(6) 1195±90 **
VA(7) 1934±275 ** **
VV(7) 1400±200 ** * **
VVC to
VV(3) 245±33 n/a * * *
VA(3) 399±28 n/a * * * n/a
AA(6) 1544±294 ** ** * ns * *
AA+(2) 2023±303 n/a n/a n/a n/a n/a n/a n/a
AA+, sheep with additional polymorphisms at codons 112 or 141. Survival times are indicated as mean ± SD. In brackets, numer of clinically affected sheep within
each transmission group. n/a, analysis not performed due to insufficient sheep numbers. Ns, no significant differences; * P < 0.05; ** P < 0.01 in the Mann–
Whitney test.
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Phenotype of PrPd accumulation in the CNS
The PrPd profiles in the brains of donors are sum-
marised and illustrated in Figure 2. All the 10 Suffolk
sheep that provided the AAS inoculum showed very
similar profiles of PrPd accumulation in the brain (pro-
file type A; Figure 2a). This was characterised by rela-
tively low amounts of intracellular PrPd (intraneuronal
and intraglial), prominent deposits of extracellular pro-
tein in association with glial cells (in both grey and white
matter; Figure 2b), and to a lesser extent in the grey
matter neuropil; other types of PrPd found were in most
instances negligible and restricted to deposits in epen-
dymal cells. A higher degree of variability was observed
amongst the six donors of the VVC inoculum
(Figure 2c), which showed variable amounts of intracel-
lular PrPd, moderate amounts of extracellular protein
and significant levels of vascular plaques (profile type X,
Figure 2d).
The PrPd profiles in the brains of the recipients are
summarised in Figure 3 and illustrated in Figure 4
(detailed values of the different PrPd types are provided
in Additional file 2). In the transmissions with the AAS
inoculum, the PrPd profile was homogeneous amongst
all AA recipients (profile type A, sheep AAS1-10,
Figures 3a and 4a) and closely resembled that of the
donors (Figures 2a and 2b). This consistency was inde-
pendent of differences in breed (3 Suffolk and 7 Chev-
iot), route of infection (5 oral and 5 subcutaneous) and
additional polymorphisms (4 non-polymorphic and 6
polymorphic). A consistent PrPd profile was found for all
VA recipients (Figure 3b) which closely resembled that
of the donors (profile type A, sheep AAS11-14), with the
exception of three of them in which extracellular PrPd in
the neuropil was slightly more prominent than extracel-
lular glia-associated PrPd (profile type A’, sheep AAS15-
17, Figure 4b). A high degree of variability was observed
in the heterologous transmission to VV recipients
(Figure 3c): one sheep showed type A profile (AAS18),
although with a few vascular plaques, another sheep
showed a type A’ profile (AAS19), three were clearly dif-
ferent, showing similar levels of intra- and extracellular
PrPd (profile type M’, sheep AAS20-22, Figure 4c) and
two showed intermediate profiles (profile types U and U’,
sheep AAS23 and 24, respectively, not illustrated), in-
cluding one sheep in which a few non-vascular plaques
were present. This variability could not be attributed to
differences in route of infection (see individual details in
Additional file 2).
In the transmissions with the VVC inoculum, the PrPd
profile was very similar amongst all VV (VVC1-3) and VA
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Figure 2 Profiles of PrPd accumulation in the brain of inocula donors. A, B: AAS: note the high degree of similarity between the individual
profiles (A), which are characterized by prominent extracellular deposits, particularly those associated to glial cells (A type; sub-pial, stellate, peri-
vascular and perivacuolar, as illustrated in B; inset, detail of peri-vascular and peri-vacuolar aggregates in white matter of the cerebral cortex).
C, D: VVC: note slight more variable and clearly different profiles (C) than in AAS donors, with prominence of vascular plaques in cerebral
cortex (X type, as illustrated in D; inset, detail of intramural and perivascular plaques in corpus striatum). IHC with R145 PrP monoclonal
antibody and haematoxylin counterstaining. Original magnifications: large images × 4, insets × 20). PrPd types (X-axis) are: ITNR: intraneuronal;
ITGL: intraglial; GLAS: glia-associated extracellular; NRPL: extracellular in grey matter neuropil; OTHR: other types. For more detailed description
see text. Y-axis indicates proportion of the different PrPd types.
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(VVC4-6) recipients (homologous and semi-homologous
transmission, Figure 3d and 3e, respectively), with pre-
dominance of intraneuronal and, particularly, intraglial
deposits and very low levels of extracellular glia-
associated PrPd (profile type M, Figure 4d). However,
they did not resemble the profiles of the inoculum
donors (Figure 2c and 2d), as they showed clearly
higher levels of intracellular PrPd and absence of vascu-
lar plaques. Again, a high degree of variability was
observed in the heterologous transmission to AA recipi-
ents (Figure 3f ): three were reminiscent of the AA reci-
pients challenged with AAS inoculum (type A, VVC7-9,
the first showing a few vascular plaques in cerebral cor-
tex), and three had similar levels of extra- and intracel-
lular deposits (VVC10-12), thus resembling some of the
VV recipients dosed with AAS inoculum (type M’). The
profiles of the last two sheep of this transmission group
did not resemble those of other donor or recipient
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Figure 3 Profiles of PrPd accumulation in the brain of recipients of either AAS (A-C) or VVC (D-F) inoculum. Individual profiles that show
high degree of similarity are identified by the same colour (red, type A; pink, type A’; green, type M; light blue, type M’; gold, type U; orange, type
U’; black, type P; brown, type CH). Note the high degree of variability amongst recipients of codon 136 heterologous transmissions (C and F),
which contrasts with the consistency of profiles amongst homologous and semi-homologous transmissions recipients for both AAS (A and B)
and VVC (D and E) inocula. PrPd types (X-axis) are: ITNR: intraneuronal; ITGL: intraglial; GLAS: glia-associated extracellular; NRPL: extracellular in grey
matter neuropil; OTHR: other types. For more detailed description see text. Y-axis indicates proportion of the different PrPd types.
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sheep: one showed abundant extracellular deposits of
PrPd in the grey matter neuropil and distinctive non-
vascular plaques throughout the brain (type P, VVC13,
Figure 4e), and the other displayed very prominent
intraneuronal and intraglial aggregates being therefore
reminiscent of experimental CH1641 scrapie (VVC14,
profile type CH, Figure 4f ). The variability in PrPd pro-
files of AA recipients did not appear to result from dif-
ferences in route of inoculation or, in the case of
Suffolk sheep, additional polymorphisms (see details in
Additional file 2).
An analysis carried out to assess the relationship be-
tween the IHC phenotype in the brain and the clinical
signs exhibited by the animals (see Additional file 2 for
individual details) indicated that pruritus had been
recorded in 7/23 (30%) sheep with IHC types A or A’, a
proportion significantly lower (P< 0.05; Fisher’s exact
test) than in those with M or M’ PrPd profiles (9/12,
67%). In contrast, signs of dysphagia were observed in a
higher proportion of sheep with A or A’ brain profiles
(14/23, 61%) than of those with M or M’ IHC types (0/
12; P< 0.001).
Western blotting in samples of obex
Positive PrPres signal was detected by WB in 45 of the
48 sheep that were positive for PrPd by IHC in the obex.
A
B
C
D
E
F
Figure 4 Examples of the brain PrPd profile types encountered in different transmission groups. A: recipient AAS1: type A profile in
cerebral cortex (note similarities with Figure 2a); inset, recipient AAS10 (type A) illustrating the absence of intracellular PrPd in deep cerebellar
nuclei despite the presence of abundant extracellular aggregates. B: recipient AAS17: type A’ profile in corpus striatum: peri-vascular PrPd in
capsula interna and abundant extracellular (peri-neuronal, linear and particulate) PrPd in neuropil but inconspicuous intraneuronal PrPd in deep
cerebellar nuclei (inset, same recipient). C: recipient VVC11 (type M’) showing co-occurrence of extracellular (linear, perineurinal, particulate and
coalescing) and intraneuronal PrPd in corpus striatum; inset: recipient VVC12 showing the same co-occurrence of intra- and extra-cellular PrPd in
deep cerebellar nuclei (type M'). D: recipient VVC1: type M profile with almost complete absence of extracellular glia-associated PrPd and some
neuropil-associated and intracellular aggregates in deep cerebral cortex layers; inset, same recipient showing abundant intraneuronal PrPd in
deep cerebellar nuclei. E: recipient VVC13 (type P profile) showing abundant extracellular PrPd in the neuropil of the thalamus and prominent
non-vascular, Kuru-type plaques (detail in inset). F: recipient VVC14 (type CH profile) showing conspicuous intracellular PrPd deposits in Purkinje
cells and in neurons and glial cells within the red nucleus (inset). IHC with R145 PrP monoclonal antibody and haematoxylin counterstaining.
Original magnifications: large images × 4 (except F, ×10); insets × 60.
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The three WB negative sheep were amongst the 10 inter-
current deaths/welfare culls, and two of them showed just
trace accumulations of PrPd in the brain. All the 38 clinic-
ally affected sheep provided positive WB reaction with
both P4 and SAF84 antibodies with the exception of one
animal, the obex sample of which did not react with P4
and showed a low molecular weight (18.7 KDa) unglycosy-
lated band with SAF84 (Figure 5); this sheep (VVC14) was
the AA Cheviot orally dosed with VVC inoculum that pro-
vided a CH1641-like PrPd profile in brain.
In the analysis of the different inoculum/recipient
combinations, differences were observed both in respect
of molecular weights (MWs) of the unglycosylated bands
and of glycoprofile. These differences, however, were
only evident with P4 antibody (see values in Additional
file 2) and not with SAF84 (data not shown). As indi-
cated earlier, the interaction between the Prnp genotype
of the recipient and the source of inoculum resulted in a
variety of PrPd brain profiles, which were shown to be
associated with molecular profiles. Thus, while no differ-
ences in MWs were found between A and A’ or between
M and M’ IHC types, the latter showed significantly
higher MW unglycosylated bands (M+M’, 20.4 ± 0.1)
than the former (A +A’, 19.9 ± 0.1; P= 0.001; Figure 6a).
In terms of glycoprofile, differences were only found in
the proportion of di- and unglycosylated bands
(Figure 6b), so that sheep with A or A’ PrPd profile types
showed significantly higher diglycosylated PrPres than
sheep with M or M’ IHC profiles (43.2 ± 0.6 vs 39.8 ± 0.8;
P< 0.01) and significantly lower levels of unglycosylated
PrPres (24.3 ± 0.5 vs 28.2 ± 0.6; P< 0.001).
Discussion
When measuring the efficiency of transmission in terms
of attack rate and survival time, the results of this ex-
periment showed that the degree of genotypic homology
between donors and recipients is a key factor in the de-
velopment of scrapie. Thus, homologous transmission
both with VVC inoculum to VV recipients and with
AAS inoculum to non-polymorphic AA recipients
resulted in markedly shorter survival times than their
heterologous counterparts. The fact that VV and VA
recipients infected with AAS showed more protracted
incubation periods than AA sheep challenged with the
same inoculum contradicts the widespread notion that
sheep of the VRQ/VRQ and VRQ/ARQ Prnp genotypes
are the most susceptible to scrapie [30]. Moreover, add-
itional polymorphisms at codons either 112 or 141 in
homozygous AA Suffolk or Cheviot sheep, respectively,
resulted in extended survival times in transmission with
AAS inoculum and an incomplete attack rate in heterol-
ogous transmission with VVC inoculum. The effect of
the T112 polymorphism has been previously documented
for natural [31] and experimental scrapie [32], and also
for experimental BSE [33], and may be related to the
low PrPc to PrPres conversion efficiency of this protein
variant observed “in vitro” [34]. In contrast, a similar ef-
fect of the F141 polymorphism has only been described
in sheep orally dosed with BSE [35] but not convincingly
for classical scrapie. Based on a non-significant reduc-
tion effect of the F141 polymorphism on the “in vitro”
convertibility of PrPc to PrPres, a neutral effect of such
polymorphism on the susceptibility to scrapie was
MW +ve AAS5 AAS22 VVC2 VVC4 VVC6 VVC5 VVC8 VVC14
A M’ M M M M A CH
P4
SAF84
Sheep ID
PrPd profile type
Figure 5 Illustrative Western blot with P4 and SAF84 antibodies in samples of obex. For individual identification of the eight sheep refer to
Additional file 2. The IHC profile types for each brain are provided at the bottom of the illustration. VVC14 is the sheep with a CH1641-like PrPd
profile.
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proposed [34]. Our study clearly shows that, for AA
recipients, even when the F141 polymorphism is in het-
erozygosity it affects susceptibility to classical scrapie.
However, none of those additional polymorphisms
appeared to have a similar effect in VA heterozygotes,
whose behaviour was entirely dependant of the source of
inoculum. While those challenged with VVC inoculum
had survival times just slightly longer than VV recipients
and clearly shorter than AA recipients, those challenged
with AAS inoculum showed the longest survival times,
even longer than VV recipients inoculated with the same
AAS source (heterologous transmission). This paradoxical
situation (sometimes referred to as over-dominance) may
be the response to a strain- or source-dependant allelic
interference phenomenon, which has been previously
documented in some murine TSE models [36] and in
scrapie-infected VRQ/AHQ heterozygotes [37]. The same
phenomenon could perhaps explain the protracted incu-
bation period of VA136RQ171 compared to VV136QQ171
sheep after SSBP/1 infection [38] or in natural conditions
[39].
Non-polymorphic AA and VV recipients showed dif-
ferent behaviour in their respective homologous chal-
lenges. Thus, AA recipients succumbed to scrapie with
19
19.5
20
20.5
21
21.5kDa
Suffolk AA to
AA VA VV
Cheviot VV to
VV VA AA
A
35 40 45 50 55 60
25
35
30
40
20 1525
30
35
40
B Ung.
Monog.
Dig.
Figure 6 Molecular characteristics of PrPres (WB with P4 antibody) in obex samples. Sheep recipients of the different transmission groups
are colour-coded to match the IHC profiles shown in Figure 3. A: Molecular weights (MWs in kDa) of the unglycosylated band: note the
association between AAS inoculum (circles), A and A’ PrPd profiles (red and pink, respectively) and generally lower MWs, and between VVC
inoculum (squares), M and M’ IHC profiles (green and light blue, respectively) and generally higher MWs (for statistical analysis refer to text). B:
Triplot representation of the glycoprofiles as proportion of unglycosylated (ung., green scale and grid), monoglycosylated (monog, black scale
and grid) and diglycosylated band (dig, blue scale and grid): note that 11 of 12 sheep with M or M’ IHC profiles have more than 26% of
unglycosylated PrPres, whereas 18 of 23 with A or A’ PrPd profiles have 26% or less unglycosylated PrPres (dotted green line). Similarly, 11 of 12
sheep with M or M’ IHC profiles have less than 43% of diglycosylated PrPres, whereas 15 of 23 with A or A’ PrPd profiles have 43% or more
diglycosylated PrPres (dotted blue line). For statistical analyses refer to text. The only one sheep with a CH type of PrPd profile (see Figure 3) is not
represented as it did not react with P4 antibody in the WB.
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incubation periods (~700 days) and brain IHC pheno-
types (type A) similar to those observed in the naturally
affected sheep that provided the AAS inoculum (see
Figures 1a, 2a and 3a). In contrast, the VV recipients
developed scrapie with a much shorter incubation period
(~250 days) than that observed in the natural cases pro-
viding the VVC inoculum (~700 days, assuming infec-
tion at around birth; see Figure 1b), and also their brain
PrPd profile was, although consistent (type M; see
Figure 3d), clearly different from that of the donors (type
X; see Figure 2c). It has been proposed that the higher
efficiency of the oral route compared to the natural in-
fection, both in terms of PrPd accumulation dynamics in
brain and incubation period, is possibly due to differ-
ences in dose and exposure to infection between these
two scenarios [40]. The results of the homologous trans-
mission to AA sheep of our study does not support a
consistent or necessarily higher efficiency of the oral
route compared to natural infection but could, at least
partially, explain the differences between VV donors and
recipients. A different explanation is however possible,
particularly in view of the differences in brain PrPd IHC
phenotype: that the VV inoculum contained a mixture of
strains and that one prevails in low dose natural infec-
tion while a different one is responsible for disease pro-
gression after high dose oral infection. This hypothesis
would be in agreement with the previously reported iso-
lation of two different murine scrapie strains, ME7 and
221 C, from VRQ/VRQ sheep of the farm providing the
VVC inoculum of this experiment [41].
With regard to the clinical signs observed in this ex-
periment, the positive and negative associations of the
VV genotype with signs of pruritus and dysphagia, re-
spectively, are in agreement with those found in natural
scrapie cases [10]. From the brain PrPd profiles obtained
in this experiment it would further appear that predom-
inantly extracellular deposits (types A and A’) would be
associated with signs of dysphagia, while more promin-
ent intracellular PrPd aggregates (types M and M’) would
be associated with pruritus. However, the interpretation
of this apparent association has to be cautious as, for ex-
ample, the sheep with a CH1641-like profile (almost
90% of intracellular PrPd) did not show evident pruritus.
It has been suggested that, for natural scrapie, the IHC
PrPd profiles in the brain are mainly driven by the sheep
Prnp genotype [11,12], and that the same factor is key in
determining the lesion profile in mice inoculated with
natural scrapie isolates [42,43]. In contrast, other studies
have shown that variability of brain PrPd profiles can
occur within naturally infected sheep of a single geno-
type [16], confirming previous experimental results that
indicated that the source of infection can also play a role
in the pathological phenotype [14,15,17-19]. The results
of the present experiment clearly support the latter
notion since: i) sheep recipients of the same genotype
can have different profiles, depending on the infecting
source (compare, for example, VA sheep infected with
the two inocula in Figure 3), ii) on cross-genotype,
heterologous transmission, sheep recipients of the same
genotype, either VV or AA, can show a diversity of pro-
files, and iii) sheep of different genotypes can show simi-
lar profiles not only when infected with the same source,
but also when challenged with different sources. In sum-
mary, the IHC examination of the brain of clinically
affected sheep within this study suggests that homolo-
gous and semi-homologous genotype transmission of
scrapie results in consistent brain PrPd profiles in the
recipients. These can be indistinguishable from (AAS to
AA and VA) or different (VVC to VV and VA) the pro-
file of the source, possibly depending on the presence of
one or more strains of the agent in the inoculum, as
already mentioned. In contrast, codon 136 heterologous
transmissions result in a diversity of brain PrPd profiles,
which in some cases appear to be driven by the source
of inoculum, in others by the host genotype and in
others again by neither of these factors. The emergence
of P-type and H-type profiles (VVC13 and VVC14, re-
spectively) in AA recipients challenged with VVC is an
example of the latter. The finding of a CH1641-like pro-
file (CH-type) is not surprising since the isolation of this
experimental source originated from a VRQ/VRQ sheep
from the same flock as the VVC inoculum donors used
in this experiment [19]. It is worth noting that this IHC
phenotype appeared in the only LF141 sheep of this
transmission group, although any extrapolation on the
basis of a single example would be premature.
Correlations were found between IHC and molecular
profiles. Thus, predominantly extracellular PrPd (types A
and A’) is associated with more abundant diglycosylated
PrPres and little unglycosylated protein of slightly lower
molecular weight, while prominent intracellular PrPd
(types M and M’) correlates with more abundant ungly-
cosylated WB bands of higher molecular weight. One
possible explanation would be that, while extracellular
PrPd is mostly intact, full length [18] and fully glycosy-
lated, once it is internalised in the endosomal/lysosomal
system it is not only cleaved at the N-terminus but also
sugar residues are digested. Another explanation would
be that in some source/host combinations, conversion of
PrPc to PrPd takes place, at least partially, inside the cell,
before glycosylation of PrPc takes place; this would
be in agreement with reports demonstrating that ungly-
cosylated PrPc is mainly intracellular and fully functional
[44].
In conclusion, the disease phenotype arising in the
natural sheep host upon experimental transmission
appears to result from a complex interaction between
donor and recipient factors. Amongst the donor factors,
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the Prnp genotype and the nature of the strain (and its
presence as single or multiple strains) in the inoculum
are likely to play a role; amongst the recipient factors
the Prnp genotype does not explain all of the variability
observed, arguing for other, probably genetic, factors to
be involved. Whether or not the consistency or variabil-
ity of disease phenotypes found in sheep bears signifi-
cance in terms of strain diversity will be better
understood by studying their correlation with other bio-
logical properties, for which bioassays in rodent models
are currently underway.
Additional files
Additional file 1: Clinical monitoring and clinical signs. Details of
clinical examinations performed and of frequency and severity of
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Additional file 2: Individual details of 38 recipients that reached
clinical end point grouped by their transmission group. Individual
sheep data on source of inoculum, route of inoculation, Prnp genotype,
breed, survival time, clinical signs, IHC profiles and WB results.
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